Skip to main content
. 2016 Mar 5;3:336–345. doi: 10.1016/j.toxrep.2016.03.001

Table 2.

Measurement of circulating plasma levels of EGCG at various time points post treatment with i.v, i.p and p.o routes of administration. Data expressed as mean estimates for various pharmacokinetic parameters.

Parameter Unit Mean estimated values
i.v i.p p.o
AUC0–t h mg/l 5.96 1.87 0.40
AUC0–inf h mg/l 6.22 1.90 0.47
AUMC0–t h mg/l 8.96 3.14 1.13
AUMC0–inf h mg/l 9.23 3.30 1.33
MRT hour 1.48 1.74 2.86
t1/2 minutes 11.40 53.40 68.40
Tmax minutes 10.00 45.00 45.00
Cmax μg/ml 8.63 2.10 0.14
peak.concn uM 18.84 4.56 0.30
Tlast minutes 480.00 360.00 360.00
Clast μg/ml 0.06 0.00 0.06
Bioavailability % 100.00 31.37 6.71